Form 4: Medtronic Director Gregory P. Lewis Reports Share Transactions
SEC Form 4 Filing
Director Gregory P. Lewis reports acquisition of restricted stock units and shares, as well as shares withheld for tax obligations.
Summary
- Gregory P. Lewis, a director at Medtronic plc, reported transactions involving the company's ordinary shares.
- On April 28, 2025, Lewis acquired 2,083 shares of restricted stock units at a price of $84.04.
- He also acquired 62 shares through dividend reinvestment.
- On April 29, 2025, 181 shares were disposed of at $84.60 to cover tax obligations related to vesting restricted stock units.
- Following these transactions, Lewis beneficially owns 3,785 ordinary shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document simply reports transactions without expressing any positive or negative outlook.
Positives
- The acquisition of restricted stock units indicates confidence in the company's future performance.
Negatives
- The disposal of shares to cover tax obligations could be perceived as a minor negative, although it's a common practice.
Risks
- There are no specific risks highlighted in this document, as it primarily details share transactions.
Future Outlook
The document does not contain any specific forward-looking statements.
Industry Context
This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency to investors regarding the actions of company directors.
Comparison to Industry Standards
- Form 4 filings are standard practice for directors and officers of publicly traded companies like Medtronic, similar to filings made by executives at comparable firms such as Johnson & Johnson and Abbott Laboratories.
- The transactions reported are typical for executive compensation packages, which often include grants of restricted stock units that vest over time.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 04/03/2025 | Date of Power of Attorney execution. |
| 04/28/2025 | Date of restricted stock units acquisition. |
| 04/29/2025 | Date of shares withheld for tax payment. |
| 04/30/2025 | Date of signature for the report. |
Keywords
Medtronic, Director, Share Transactions, Form 4, Restricted Stock Units, Dividend Reinvestment, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.